• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Bt De Investments Inc. converted options into 95,281,277 shares and was granted 14,662,765 shares (SEC Form 4)

    5/29/26 4:30:34 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BTI alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    BT DE Investments Inc.

    (Last)(First)(Middle)
    103 FOULK ROAD, SUITE 111

    (Street)
    WILMINGTON DELAWARE 19803

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Charlotte's Web Holdings, Inc. [ CWBHF ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    DirectorX10% Owner
    Officer (give title below)Other (specify below)
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    05/28/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    XForm filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Common Shares05/28/2026C95,281,277(1)A$0.68(2)95,281,277D(3)(4)
    Common Shares05/28/2026A14,662,765(5)A$0.68(6)109,944,042D(3)(4)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Convertible Debenture$1.45(7)05/28/2026H$54,662,323(8)05/28/202611/14/2029Common Shares37,670,540(9)0D(3)(4)
    Convertible Debenture$0.68(10)05/28/2026P$54,662,323(8)05/28/202611/14/2029Common Shares95,281,277(9)95,281,277D(3)(4)
    Convertible Debenture$0.68(10)05/28/2026C$54,662,323(8)05/28/202611/14/2029Common Shares95,281,277(11)$0(11)0D(3)(4)
    1. Name and Address of Reporting Person*
    BT DE Investments Inc.

    (Last)(First)(Middle)
    103 FOULK ROAD, SUITE 111

    (Street)
    WILMINGTON DELAWARE 19803

    (City)(State)(Zip)

    UNITED STATES

    (Country)

    Relationship of Reporting Person(s) to Issuer
    DirectorX10% Owner
    Officer (give title below)Other (specify below)
    1. Name and Address of Reporting Person*
    British American Tobacco p.l.c.

    (Last)(First)(Middle)
    GLOBE HOUSE, 4 TEMPLE PLACE

    (Street)
    LONDONUNITED KINGDOMWC2R 2PG

    (City)(State)(Zip)

    UNITED KINGDOM

    (Country)

    Relationship of Reporting Person(s) to Issuer
    DirectorX10% Owner
    Officer (give title below)Other (specify below)
    Explanation of Responses:
    1. Reflects common shares issued upon conversion of the Convertible Debenture (the "Debenture") including accrued and unpaid interest thereunder.
    2. Represents a conversion price of C$0.94 Canadian dollars, converted to U.S. dollars at the exchange rate of U.S.$1.00 to C$1.3783 reported by the Bank of Canada on May 22, 2026.
    3. BT DE Investments Inc. ("BT DE") is a wholly owned subsidiary of BATUS Holdings Inc., which is a wholly owned subsidiary of Louisville Securities Limited, which is a wholly owned subsidiary of British-American Tobacco (Holdings) Limited, which is a wholly owned subsidiary of B.A.T. Industries p.l.c., which is a wholly owned subsidiary of Weston (2009) Limited, which is a wholly owned subsidiary of British American Tobacco (2009) Limited, which is a wholly owned subsidiary of British American Tobacco (2012) Limited, which is a wholly owned subsidiary of British American Tobacco (1998) Limited, which is a wholly owned subsidiary of British American Tobacco p.l.c. ("BAT"). BAT and the aforementioned wholly owned subsidiaries of BAT are collectively referred to herein as the "BAT Entities." The BAT Entities may be deemed to beneficially own the securities held by BT DE by virtue of their indirect ownership of BT DE as described herein.
    4. (Continued from footnote 3) The BAT Entities disclaim such beneficial ownership except to the extent of their pecuniary interest therein.
    5. On March 30, 2026, BT DE agreed to purchase from the Issuer U.S.$10,000,000 of common shares for C$0.94 per share. The closing of such purchase occurred on May 28, 2026.
    6. Represents a purchase price of C$0.94 Canadian dollars, converted to U.S. dollars at the exchange rate of U.S.$1.00 to C$1.3783 reported by the Bank of Canada on May 22, 2026.
    7. Represents a conversion price of C$2.00 Canadian dollars, converted to U.S. dollars at the exchange rate of U.S.$1.00 to C$1.3783 reported by the Bank of Canada on May 22, 2026.
    8. Represents a principal amount of C$75,341,080 Canadian dollars, converted to U.S. dollars at the exchange rate of U.S.$1.00 to C$1.3783 reported by the Bank of Canada on May 22, 2026.
    9. The first two transactions reported in Table II above involved an amendment to the Debenture on May 28, 2026 to reduce the then-current conversion price per share from C$2.00 per share to C$0.94 per share. Consistent with existing SEC interpretive and no-action positions, the amendment is reported above as if such reduction consisted of the cancellation of the "old" Debenture and the acquisition of a "new" Debenture. BT DE did not actually dispose of the Debenture as part of the amendment.
    10. Represents a conversion price of C$0.94 Canadian dollars, converted to U.S. dollars at the exchange rate of U.S.$1.00 to C$1.3783 reported by the Bank of Canada on May 22, 2026.
    11. On May 28, 2026, BT DE converted the entire C$75,341,080 initial principal amount of the Debenture and all accrued and unpaid interest thereunder into common shares.
    BT DE Investments Inc., /s/ Natalie Bucceri, President05/29/2026
    British American Tobacco p.l.c, /s/ Caroline Ferland, Secretary05/29/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $BTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BTI

    DatePrice TargetRatingAnalyst
    12/12/2025Buy
    Kepler
    9/8/2025$62.00Hold → Buy
    Argus
    9/2/2025Sector Perform → Underperform
    RBC Capital Mkts
    7/9/2025Buy
    Jefferies
    4/30/2025Buy
    BofA Securities
    1/27/2025Neutral → Buy
    UBS
    10/3/2024$33.00Overweight → Underweight
    Morgan Stanley
    1/23/2024Neutral
    UBS
    More analyst ratings

    $BTI
    SEC Filings

    View All

    SEC Form 6-K filed by British American Tobacco Industries p.l.c.

    6-K - British American Tobacco p.l.c. (0001303523) (Filer)

    6/4/26 11:56:20 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by British American Tobacco Industries p.l.c.

    6-K - British American Tobacco p.l.c. (0001303523) (Filer)

    6/2/26 4:33:26 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by British American Tobacco Industries p.l.c.

    6-K - British American Tobacco p.l.c. (0001303523) (Filer)

    6/1/26 12:03:02 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results

    Anticipated CMMI Medicare Pilot Program Participation, Regulatory Momentum, and Cost Structure Improvements Position Company for Growth and Pathway to ProfitabilityLOUISVILLE, Colo., March 31, 2026 /CNW/ - (TSX:CWEB) (OTC:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter and year ended December 31, 2025. All amounts are expressed in U.S. dollars, unless otherwise stated. SUBSEQUENT MATERIAL EVENTS BA

    3/31/26 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Announces Transaction with BAT: Debenture Conversion and US$10M Equity Investment to Strengthen Balance Sheet

    Transaction Addresses Capital Structure and Supports Near-Term Operating Priorities, Including Anticipated CMMI Medicare Pilot Program ParticipationLOUISVILLE, Colo., March 30, 2026 /CNW/ - (TSX:CWEB) (OTCQB:CWBHF) Charlotte's Web Holdings, Inc., a botanical wellness innovation company and the market leader in cannabidiol ("CBD") hemp extract wellness products, today announced a transaction with BT DE Investments, Inc. ("BAT"), a subsidiary of British American Tobacco plc (NYSE:BTI), comprising two components: (i) amendment and conversion of BAT's outstanding C$75.3 million principal amount (approximately US$54 million) of the convertible debenture, as well as all accrued interest, into comm

    3/30/26 10:59:00 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Better-for-You Stimulant Formats Gain Scale as Consumer Demand Reshapes Delivery Landscape

    Issued on behalf of Doseology Sciences Inc.VANCOUVER, BC, March 4, 2026 /CNW/ -- USANewsGroup.com News Commentary -- Consumer habits continue to shift, and there's no better example to point at than the rise of pouches. The global oral nicotine pouch market is projected to surge from $5.4 billion in 2024 to over $25 billion by 2030, reflecting a 29.6% CAGR[1]. On top of this, consumer habits are shifting toward tobacco-free formats which are accelerating alongside demand for functional, portable energy delivery systems that eliminate liquid bulk and sugar crashes[2]. This convergence is channeling capital toward consumer goods platforms built around precise dosing, clean ingredients, and mod

    3/4/26 11:51:00 AM ET
    $BTI
    $CELH
    $KDP
    Medicinal Chemicals and Botanical Products
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    $BTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Kepler initiated coverage on British American Tobacco

    Kepler initiated coverage of British American Tobacco with a rating of Buy

    12/12/25 8:49:35 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    British American Tobacco upgraded by Argus with a new price target

    Argus upgraded British American Tobacco from Hold to Buy and set a new price target of $62.00

    9/8/25 8:36:41 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    British American Tobacco downgraded by RBC Capital Mkts

    RBC Capital Mkts downgraded British American Tobacco from Sector Perform to Underperform

    9/2/25 8:32:33 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Bt De Investments Inc. converted options into 95,281,277 shares and was granted 14,662,765 shares (SEC Form 4)

    4 - British American Tobacco p.l.c. (0001303523) (Reporting)

    5/29/26 4:30:34 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3 filed by new insider Bt De Investments Inc.

    3 - British American Tobacco p.l.c. (0001303523) (Reporting)

    11/23/22 4:29:54 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Leadership Updates

    Live Leadership Updates

    View All

    Charlotte's Web Appoints M. Borgia Walker to Board of Directors

    Accomplished Executive Brings Three Decades of Transformation and Financial Leadership Experience from Global Consumer Goods and Financial Services Industries LOUISVILLE, Colo., Oct. 21, 2025 /PRNewswire/ - (TSX:CWEB) (OTCQB:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, is pleased to announce the appointment of M. Borgia Walker to its Board of Directors, effective November 1, 2025. Ms. Walker brings extensive global leadership experie

    10/21/25 8:15:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    British American Tobacco p.l.c investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2024 deadline

    Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla

    1/24/24 6:21:08 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Announces Appointment of Bill Morachnick as Chief Executive Officer

    Provides Update on Majority Voting Policy Process LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web.  CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (C

    9/13/23 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

    2/9/24 6:03:23 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

    2/9/24 5:46:32 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

    SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

    1/26/24 4:56:06 PM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    $BTI
    Financials

    Live finance-specific insights

    View All

    Charlotte's Web Reports 2025 Fourth Quarter and Full Year Financial Results

    Anticipated CMMI Medicare Pilot Program Participation, Regulatory Momentum, and Cost Structure Improvements Position Company for Growth and Pathway to ProfitabilityLOUISVILLE, Colo., March 31, 2026 /CNW/ - (TSX:CWEB) (OTC:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), a botanical wellness innovation company and the market leader in cannabidiol (CBD) hemp extract wellness products, today announced results for the quarter and year ended December 31, 2025. All amounts are expressed in U.S. dollars, unless otherwise stated. SUBSEQUENT MATERIAL EVENTS BA

    3/31/26 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Reports 2024 First Quarter Financial Results

    LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile

    5/8/24 7:07:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    Charlotte's Web Reports 2023 Second Quarter Financial Results

    Encouraging CBD regulatory progress in CongressNet revenue of $16.0M vs. $18.9M YoYCash increased to $61.7M LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023.  Regulatory Update During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.

    8/10/23 7:33:00 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care